Short-acting beta-agonist overuse is risky, but how do users with asthma perceive and respond to this risk?

B. Saini; E. McEwin; L. Smith; C. Armour; B. Toelle

Short-acting beta-agonist overuse is risky, but how do users with asthma perceive and respond to this risk?

B. Saini, E. McEwin, L. Smith, C. Armour, B. Toelle

Research output: Contribution to journal › Meeting abstract › peer-review

Original language	English
Pages (from-to)	249
Number of pages	1
Journal	Respirology
Volume	29
Issue number	S1
Publication status	Published - Mar 2024
Event	TSANZSRS 2024 The Australia & New Zealand Society of Respiratory Science and The Thoracic Society of Australia and New Zealand (ANZSRS/TSANZ) Annual Scientific Meeting for Leaders in Lung Health & Respiratory Science - Gold Coast, Australia Duration: 22 Mar 2024 → 26 Mar 2024

Cite this

@article{1955edf59b074bd6adc0cc1bb8561a5d,

title = "Short-acting beta-agonist overuse is risky, but how do users with asthma perceive and respond to this risk?",

author = "B. Saini and E. McEwin and L. Smith and C. Armour and B. Toelle",

year = "2024",

month = mar,

language = "English",

volume = "29",

pages = "249",

journal = "Respirology",

issn = "1323-7799",

publisher = "John Wiley \& Sons",

number = "S1",

note = "TSANZSRS 2024 The Australia \& New Zealand Society of Respiratory Science and The Thoracic Society of Australia and New Zealand (ANZSRS/TSANZ) Annual Scientific Meeting for Leaders in Lung Health \& Respiratory Science ; Conference date: 22-03-2024 Through 26-03-2024",